Reversal of Innovar-induced postanesthetic somnolence and disorientation with physostigmine.
D000328:Adult; D000771:Anesthesia, Intravenous / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D003072:Cognition Disorders / Q000139:chemically induced*; D003221:Confusion / Q000139:chemically induced / Q000188:drug therapy; D003244:Consciousness Disorders / Q000139:chemically induced / Q000188:drug therapy; D004329:Droperidol / Q000009:adverse effects*; D005260:Female; D005283:Fentanyl / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010830:Physostigmine / Q000627:therapeutic use*
D000777:Anesthetics; D010830:Physostigmine; D004329:Droperidol; D005283:Fentanyl